The INSPIRIS RESILIA valve is designed for people diagnosed with a malfunctioning aortic valve.
Aortic stenosis, one of the most common types of heart valve disease, is when a valve opening narrows, reducing blood flow through the aorta to the rest of your body. One cause of aortic stenosis may be calcium build-up on your heart valve, which hardens your valve leaflets.
Aortic stenosis can vary in severity but progresses over time if left untreated.
Aortic regurgitation occurs when your heart's aortic valve leaflets don't close completely.
As a result, some of the blood pumped out of your heart's main pumping chamber leaks backward. This condition is also called aortic insufficiency or leaky aortic valve.
Edwards Lifesciences is a leading innovator in bovine tissue heart valves.
The INSPIRIS RESILIA valve is made with bovine (cow) heart tissue that has been preserved with a special Edwards technology to reduce calcium build-up on the valve tissue.1 Less calcium build-up could potentially allow the valve to last longer.*
The INSPIRIS RESILIA valve uses an expandable valve frame designed to enable less-invasive procedures in the future. Talk to your doctor about your risks of needing future surgeries and how the INSPIRIS RESILIA valve may help.
*RESILIA tissue has not been studied for long-term results in patients.
The INSPIRIS RESILIA valve uses a first-of-its-kind expandable valve frame designed to enable less-invasive procedures in the future. It’s also radiopaque so that your doctor can see it under X-ray.
Talk to your doctor about your chances of needing future surgeries and how the INSPIRIS RESILIA valve is designed to help.
Valvular heart disease (VHD) occurs when one or more valves in your heart is damaged or diseased and does not work properly.
RESILIA tissue is the newest heart valve tissue technology from Edwards Lifesciences. We have been innovating on bovine pericardial (cow) tissue technology since the 1980s. Our goal is to make more durable, longer lasting artificial heart valves. We are currently in the 4th generation of our tissue treatment process, which has anti-calcification technology. By slowing down the calcium buildup of our valves, we hope they will last longer in patients.
There is a body of evidence that shows that RESILIA tissue technology lessens the amount of calcium build-up in patients as well as ongoing studies to demonstrate this evidence long-term.
Explanted valves from an animal study1 showing less calcium build-up in the valve with RESILIA tissue compared to the valve with regular tissue.*
*RESILIA tissue has not been studied for long-term results in patients.
We are committed to providing the highest levels of customer service to help our patients improve their quality of life. For any questions, please contact the Edwards Patient Support Center.
Give us a call
Send us an email
Indications: For use in replacement of native or prosthetic aortic heart valves.
Contraindications (Who should not receive): There are no known contraindications with the use of the INSPIRIS RESILIA aortic valve.
Complications and Side Effects: The risks with the INSPIRIS RESILIA aortic valve are similar to risks with other heart valves, and include the following:
These could lead to the need for reoperation to replace the valve, permanent disability, or death.
This is not a complete list of all the risks that can occur with heart valve surgery. Your doctor can give you more information about these and other risks. This information is not a substitute for talking with your doctor.
Indications: For use in replacement of native or prosthetic mitral heart valves.
Contraindications (Who should not receive): There are no known contraindications with the use of the MITRIS RESILIA mitral valve.
Complications and Side Effects: The risks with the MITRIS RESILIA mitral valve are similar to risks with other heart valves, and include the following:
These could lead to the need for reoperation to replace the valve, permanent disability, or death.
This is not a complete list of all the risks that can occur with heart valve surgery. Your doctor can give you more information about these and other risks. This information is not a substitute for talking with your doctor.
Indications: For use in replacement of native or prosthetic aortic heart valves and the associated repair and replacement of a damaged or diseased ascending aorta.
Contraindications (Who should not receive): There are no known contraindications with the use of the KONECT RESILIA aortic valve conduit.
Complications and Side Effects: The risks with the KONECT RESILIA aortic valve conduit are similar to risks with other heart valves, and include the following:
These could lead to the need for reoperation to replace the valve, permanent disability, or death.
This is not a complete list of all the risks that can occur with heart valve surgery. Your doctor can give you more information about these and other risks. This information is not a substitute for talking with your doctor.
CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.